Neoplasms, Glandular and Epithelial  >>  Pexa-Vec (pexastimogene devacirepvec)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pexa-Vec (pexastimogene devacirepvec) / SillaJen, Transgene
NCT01329809: Neoadjuvant Study of Recombinant Vaccinia Virus to Treat Metastatic Colorectal Carcinoma in Patients Undergoing Complete Resection of Liver Tumors

Terminated
2a
2
Canada
Recombinant Vaccinia GM-CSF; RAC VAC GM-CSF (JX-594), JX-594
Jennerex Biotherapeutics
Colorectal Carcinoma
01/12
03/13
NCT00554372: A Study of Recombinant Vaccinia Virus to Treat Unresectable Primary Hepatocellular Carcinoma

Completed
2
30
US, Canada, RoW
JX-594: Recombinant vaccinia virus (TK-deletion plus GM-CSF)
Jennerex Biotherapeutics
Carcinoma, Hepatocellular
12/11
02/13

Download Options